Timwell Forms $20 Million JV with ReWalk for China Sales of Exoskeleton

Timwell, a Hong Kong medical device company, will invest $20 million in ReWalk Robotics, an Israeli company that has developed a soft-suit exoskeleton to help patients walk after a stroke. Timwell, ReWalk and RealCan Ambrum Investment will form a China JV to develop, produce and market the Restore exoskeleton in greater China . After the tranched investment is complete, Timwell will own 16 million shares of ReWalk, a 35% share of the company. More details.... Stock Symbol: (NSDQ:RWLK) Share this with colleagues: // //